Aldometanib (LXY-05-029) is an orally active aldolase inhibitor. Aldometanib prevents FBP from binding to v-ATPase-associated aldolase and activates lysosomal AMPK. Aldometanib can be used for the research of metabolic homeostasis.

 

Brand: BCM

 

Isomeric SMILES: CCCCCCCCCCCCCCCCN1C=C[N+](=C1C)CC2=C(C=CC=C2Cl)Cl.[I-]  

 

InChIKey: QGSVKLIYXRLMTB-UHFFFAOYSA-M  

 

InChI: InChI=1S/C27H43Cl2N2.HI/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20-30-21-22-31(24(30)2)23-25-26(28)18-17-19-27(25)29;/h17-19,21-22H,3-16,20,23H2,1-2H3;1H/q+1;/p-1

 

Attribute
[Chem Name]	1-[(2,6-dichlorophenyl)methyl]-3-hexadecyl-2-methylimidazol-1-ium;iodide
[Synonym]	Aldometanib; LXY-05-029
[Formula]	C27H43Cl2IN2
[Molecular]	593.45
[Form]	Off-white to light yellow solid
[Storage]	4°C, sealed storage, away from moisture

Goods Tag